Record damages awarded by Paris court in pemetrexed patent battle
France becoming more friendly to pharma IP, experts suggest, following decision over blockbuster cancer treatment Alimta
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.